Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Inserm · Université Paris-Saclay · +29 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
631
total citations
- FWCI
- 48.94
- Percentile
- 100%
- References
- 69
Citations per year
Authors
43- LDLisa Derosa
Inserm, Université Paris-Saclay, Institut Gustave Roussy, La Ligue Contre le Cancer
- BRBertrand Routy
Centre Hospitalier de l’Université de Montréal
- AMAndrew Maltez Thomas
University of Trento, Istituti di Ricovero e Cura a Carattere Scientifico, European Institute of Oncology
- VIValerio Iebba
University of Trieste
- GZGérard Zalcman
Université Claude Bernard Lyon 1, Délégation Paris 7, Université Paris Cité, Assistance Publique – Hôpitaux de Paris
Topics & keywords
Topics
Keywords
- Akkermansia muciniphila
- Akkermansia
- Biology
- Internal medicine
- Oncology
- Gut flora
- Gastroenterology
- Cancer research
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- CPCancer Prevention and Research Institute of TexasAward: RP170067
- CCelgene
- APAssociation pour la Recherche sur le Cancer
- TPTaiho Pharmaceutical
- NNovocure
- SFSeerave Foundation
- EE-Rare
- RTRelay Therapeutics
- ECEuropean CommissionAwards: 716575, 825410, 818368, MASTER-818368, ONCOBIOME-825410
- ANAgence Nationale de la RechercheAwards: 2017-, ANR-18-IBHU-0002, ANR-18, E-Rare-2, ANR-16-RHUS-0008, 19-CE15-0029-01
- FLFondation Leducq
- INInstitut National de la Santé et de la Recherche Médicale
- FPFondation pour la Recherche Médicale
- MDMinistero dell’Istruzione, dell’Università e della RicercaAward: RBFR13EWWI_001
- FAFondation ARC pour la Recherche sur le Cancer
- LCLigue Contre le Cancer
- IUInstitut Universitaire de France
- INInstitut National Du CancerAwards: 19-CE15-0029-01, DGOS-Inserm_12551
- IGInstitut Gustave-Roussy
- DGDirection Générale de l’offre de Soins
- CDChancellerie des Universités de Paris
- SServier
- FGFondation Gustave Roussy
- SSymphogen
- DVDa Volterra
- IDInstitut Du Cancer de Montréal
- NINational Institutes of HealthAwards: 1U01CA230551, RP170067
- GGenentech
- SSamsung
- H2Horizon 2020 Framework ProgrammeAwards: MASTER-818368, 818368, ONCOBIOME-825410, 825410
- CICanadian Institutes of Health Research
- LILabex Immuno-Oncology
- NCNational Cancer InstituteAward: 1U01CA230551
- IOInstitute of Cancer Research
- DSDaiichi Sankyo Europe